First real-world experience with inclisiran in Spain: Efficacy, safety, and prescription patterns in clinical practice
{{output}}
Background: Low-density lipoprotein cholesterol (LDL-C) is a key causal factor in atherosclerotic cardiovascular disease. Although statins remain the cornerstone of treatment, their use is limited by adverse effects, variable res... ...
